33 related articles for article (PubMed ID: 14665956)
1. Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells.
Bouchelouche K; Alvarez S; Andersen L; Nordling J; Horn T; Bouchelouche P
J Urol; 2004 Jan; 171(1):462-6. PubMed ID: 14665956
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 beta, tumor necrosis factor-alpha and lipopolysaccharide induce expression of monocyte chemoattractant protein-1 in calf aortic smooth muscle cells.
Meng F; Deng Z; Ni J
J Tongji Med Univ; 2000; 20(1):36-8. PubMed ID: 12845752
[TBL] [Abstract][Full Text] [Related]
3. Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha.
Bouchelouche K; Alvarez S; Horn T; Nordling J; Bouchelouche P
Urology; 2006 Jan; 67(1):214-9. PubMed ID: 16413378
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-4 and 13 induce the expression and release of monocyte chemoattractant protein 1, interleukin-6 and stem cell factor from human detrusor smooth muscle cells: synergy with interleukin-1beta and tumor necrosis factor-alpha.
Bouchelouche K; Andresen L; Alvarez S; Nordling J; Nielsen OH; Bouchelouche P
J Urol; 2006 Feb; 175(2):760-5. PubMed ID: 16407046
[TBL] [Abstract][Full Text] [Related]
5. Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625885
[TBL] [Abstract][Full Text] [Related]
6. Urine Proteomic Study in OAB Patients-Preliminary Report.
Futyma K; Nowakowski Ł; Ziętek-Strobl A; Kamińska A; Taoussi N; Rechberger T
J Clin Med; 2020 May; 9(5):. PubMed ID: 32397227
[TBL] [Abstract][Full Text] [Related]
7. Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.
Furuta A; Yamamoto T; Suzuki Y; Gotoh M; Egawa S; Yoshimura N
Int Urogynecol J; 2018 Jul; 29(7):961-966. PubMed ID: 29372285
[TBL] [Abstract][Full Text] [Related]
8. Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease.
Jhang JF; Kuo HC
Int Neurourol J; 2016 Nov; 20(Suppl 2):S95-104. PubMed ID: 27915472
[TBL] [Abstract][Full Text] [Related]
9. Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.
Tyagi P; Motley SS; Kashyap M; Pore S; Gingrich J; Wang Z; Yoshimura N; Fowke JH
Int Urol Nephrol; 2015 Jul; 47(7):1051-8. PubMed ID: 25924782
[TBL] [Abstract][Full Text] [Related]
10. The role(s) of cytokines/chemokines in urinary bladder inflammation and dysfunction.
Gonzalez EJ; Arms L; Vizzard MA
Biomed Res Int; 2014; 2014():120525. PubMed ID: 24738044
[TBL] [Abstract][Full Text] [Related]
11. Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.
Hughes FM; Vivar NP; Kennis JG; Pratt-Thomas JD; Lowe DW; Shaner BE; Nietert PJ; Spruill LS; Purves JT
Am J Physiol Renal Physiol; 2014 Feb; 306(3):F299-308. PubMed ID: 24285499
[TBL] [Abstract][Full Text] [Related]
12. Increased serum adipokines implicate chronic inflammation in the pathogenesis of overactive bladder syndrome refractory to antimuscarinic therapy.
Liu HT; Jiang YH; Kuo HC
PLoS One; 2013; 8(10):e76706. PubMed ID: 24098552
[TBL] [Abstract][Full Text] [Related]
13. Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.
Yokoyama H; Oguchi T; Goins WF; Goss JR; Nishizawa O; de Groat WC; Wolfe D; Krisky DM; Glorioso JC; Yoshimura N
Hum Gene Ther; 2013 Feb; 24(2):170-80. PubMed ID: 23316929
[TBL] [Abstract][Full Text] [Related]
14. Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis.
Tyagi P; Killinger K; Tyagi V; Nirmal J; Chancellor M; Peters KM
J Urol; 2012 Jun; 187(6):2243-8. PubMed ID: 22503040
[TBL] [Abstract][Full Text] [Related]
15. Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens.
Corcoran AT; Yoshimura N; Tyagi V; Jacobs B; Leng W; Tyagi P
World J Urol; 2013 Feb; 31(1):241-6. PubMed ID: 22441309
[TBL] [Abstract][Full Text] [Related]
16. Differential profile analysis of urinary cytokines in patients with overactive bladder.
Ghoniem G; Faruqui N; Elmissiry M; Mahdy A; Abdelwahab H; Oommen M; Abdel-Mageed AB
Int Urogynecol J; 2011 Aug; 22(8):953-61. PubMed ID: 21487829
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms.
St Sauver JL; Jacobsen SJ
Curr Prostate Rep; 2008 May; 6(2):67-73. PubMed ID: 19809538
[TBL] [Abstract][Full Text] [Related]
18. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study.
Tyagi P; Barclay D; Zamora R; Yoshimura N; Peters K; Vodovotz Y; Chancellor M
Int Urol Nephrol; 2010 Sep; 42(3):629-35. PubMed ID: 19784793
[TBL] [Abstract][Full Text] [Related]
19. Treatment approaches for painful bladder syndrome/interstitial cystitis.
Theoharides TC
Drugs; 2007; 67(2):215-35. PubMed ID: 17284085
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo.
Luo Y; Chen X; O'Donnell MA
Clin Exp Immunol; 2007 Feb; 147(2):370-8. PubMed ID: 17223980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
